Clinical trial
Synvisc Injections for Lumbar Facet Joint Pain
NCT00325845 · Sheltering Arms Physical Rehabilitation Hospitals, Other · Unknown status
Key facts
| NCT number | NCT00325845 |
|---|---|
| Title | Synvisc Injections for Lumbar Facet Joint Pain |
| Official title | Efficacy and Safety of Intra-Articular Synvisc Injections as Treatment of Painful Lumbar Facet Joint Arthrosis |
| Lead sponsor | Sheltering Arms Physical Rehabilitation Hospitals, Other |
| Collaborators | Genzyme, a Sanofi Company Industry Virginia Commonwealth University |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Joint Pain |
| Intervention type | Procedure |
| Interventions | Synvisc viscosupplementation |
| Enrollment | 15 |
| Start date | May 1, 2006 |
| Completion | May 1, 2008 |
| First posted | May 15, 2006 |
| Last update posted | Sep 13, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: